A new multimillion-pound research programme, involving scientists from The Institute of Cancer Research, London, is aiming to ...

Being Tested in Combination with MSD’s anti-PD-1 Therapy, KEYTRUDA® (pembrolizumab) Cambridge, UK – 10 October 2024: Microbiotica, a clinical-stage biopharma company developing a pipeline of oral ...

Genomics England is part of a nationwide team of universities, hospitals and industry led by the Francis Crick Institute ...

Melanoma-associated antigen A6 (MAGEA6) is well known to have oncogenic activity, but the underlying mechanisms by which it regulates tumor progression and chemo-resistance, especially in ...

With melanoma rates on the rise, a skin cancer doctor shares her rules for staying protected. For a product considered one of ...

So now a new multimillion-pound research programme aims to discover why at least half of all patients fail to respond to ...

A student admitted she regrets using sunbeds on a daily basis to look ‘glamorous’ as she became so dark that people claimed ...

Imlygic injections take about 10 minutes and are conducted over several months. In clinical trials, Dr. Gushchin says seven ...

Candel Therapeutics to Present Preclinical Data on Therapeutic Potential of CAN-3110 in Melanoma at SITC 2024 Annual Meeting ...

Iovance Biotherapeutics is an oncology specialist. The company's platform focuses on tumor-infiltrating lymphocytes (TILs), a ...

Sarah Lee spoke to her doctor about the 'fungus which had appeared on her scalp and was told not to worry about it. She asked ...

Scientists at the University of Oxford are creating a vaccine which teaches the immune system to recognise and attack the ...